CITY OF BIDDEFORD v. PURDUE PHARMA LP et al
| CITY OF BIDDEFORD |
| WALGREENS BOOTS ALLIANCE INC, JANSSEN PHARMACEUTICA INC, MCKESSON CORPORATION, WALGREEN CO, PURDUE PHARMA LP, RITE AID CORPORATION, RITE AID OF MARYLAND INC, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC, CVS PHARMACY INC, DOUGLAS J JORGENSEN, DO, ALLERGAN PLC, CEPHALON INC, RITE AID OF MAINE INC, ENDO HEALTH SOLUTIONS INC, TEVA PHARMACEUTICALS USA INC, JANSSEN PHARMACEUTICALS INC, WALMART INC, PURDUE FREDERICK COMPANY, ALLERGAN FINANCE LLC, INSYS THERAPEUTICS INC, PURDUE PHARMA INC, MARK E CIENIAWSKI, MD, WATSON LABORATORIES INC, JOHNSON & JOHNSON, CARDINAL HEALTH 110 LLC, ENDO PHARMACEUTICALS INC, AMERISOURCEBERGEN DRUG CORPORATION, MICHAEL B BRUEHL, MD, MALLINCKRODT ENTERPRISES LLC, ACTAVIS LLC and ACTAVIS PHARMA INC |
| 2:2019cv00092 |
| March 1, 2019 |
| US District Court for the District of Maine |
| D BROCK HORNBY |
| JOHN C NIVISON |
| NANCY TORRESEN |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1331 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 23, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 45
ORDER OF RECUSAL. JUDGE NANCY TORRESEN recused. Case reassigned to JUDGE D. BROCK HORNBY for all further proceedings By JUDGE NANCY TORRESEN. (mjlt)
|
| Filing 44 ACKNOWLEDGEMENT OF RECEIPT of Electronic Civil Case Transfer. Case electronically transferred to Northern District of Ohio has been opened on 4/16/2019 as case 1:19-op-45258. (jwr) |
| Filing 43 Multidistrict Litigation (MDL) case electronically transferred to Northern District of Ohio. (jgd) |
| Filing 42 MDL CERTIFIED TRANSFER ORDER LIFTING STAY OF CONDITIONAL TRANSFER ORDER. (jgd) |
| Filing 41 MDL ORDER LIFTING STAY OF CONDITIONAL TRANSFER ORDER (mnw) |
| Filing 40 CORPORATE DISCLOSURE STATEMENT by CARDINAL HEALTH 110 LLC. (HAWKINS, CHRISTOPHER) |
| Reset Deadlines : Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement due from CARDINAL HEALTH 110 LLC by 3/27/2019. (mnw) |
| Set Deadlines : Attorney Ethan Severance shall register for the District of Maine's Electronic Case Filing (ECF) System by 3/22/2019. Registration Forms are available on the Court's website #http://www.med.uscourts.gov/ecf-registration under the Electronic Case Files, ECF Registration Section. (mnw) |
| Filing 37 CERTIFICATION for Admission Pro Hac Vice of Ethan Severance filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989755.) (HADIARIS, JOSHUA) |
| Filing 36 CERTIFICATION for Admission Pro Hac Vice of David R. Geiger filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989752.) (HADIARIS, JOSHUA) |
| Filing 35 CERTIFICATION for Admission Pro Hac Vice of K. Neil Austin filed by JOSHUA D. HADIARIS on behalf of MICHAEL B BRUEHL, MD, MARK E CIENIAWSKI, MD (Total admission fee $ 100 receipt number 0100-1989737.) (HADIARIS, JOSHUA) |
| Filing 34 NOTICE of Appearance by JOSHUA D. HADIARIS and MARK G. LAVOIE on behalf of MICHAEL B BRUEHL and MD, MARK E CIENIAWSKI, MD (HADIARIS, JOSHUA) Modified on 3/14/2019 to clean up text (mnw). |
| Reset Deadlines: Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement due from CARDINAL HEALTH 110 LLC by 3/15/2019. (slg) |
| Filing 39 ADDITIONAL ATTACHMENTS filed by AMERISOURCEBERGEN DRUG CORPORATION re #31 State Court Record. Main Document: Entry of Appearance of Petrucelli. (Attachments: #1 Order granting AmerisourceBergen Drug Corp's Consent Motion, #2 Bruehl and Cieniawski's Consented to Motion to Extend Deadline, #3 Entry of Appearance Cahoon, #4 Order Granting McKesson Corp's Assented to Motion, #5 Order Granting Bruehl and Cieniawski's Consented to Motion, #6 Retail Pharmacy Defendants' Assented to Motion, #7 Entry of Appearance Sturtevant, #8 Order Granting Retail Pharmacy Defendants' Assented to Motion, #9 AmerisourceBergen Drug Corp's Notice of Filing Notice of Removal)(mnw) |
| Filing 38 ADDITIONAL ATTACHMENTS filed by AMERISOURCEBERGEN DRUG CORPORATION re #31 State Court Record. Main Document: York County Superior Court Docket Record for Case ALFSC-CV-2019-00008. (Attachments: #1 Superior Court Complaint, #2 Exhibit 1 to Complaint : Demand Letter to Actavis Inc, #3 Exhibit 2 to Complaint: Demand Letter to Actavis LLC, #4 Exhibit 3 to Complaint: Demand Letter to Actavis Pharma Inc, #5 Exhibit 4 to Complaint: Demand Letter to Allergan PLC, #6 Exhibit 5 to Complaint: Demand Letter to Allergan PLC, #7 Exhibit 6 to Complaint: Demand Letter to AmerisourceBergen Drug Corp, #8 Exhibit 7 to Complaint : Demand Letter to Dr. Bruehl, #9 Exhibit 8 to Complaint : Demand Letter to Cardinal Health Inc, #10 Exhibit 9 to Complaint: Demand Letter to Cephalon Inc, #11 Exhibit 10 to Complaint: Demand Letter to Dr. Cieniawski, #12 Exhibit 11 to Complaint : Demand Letter to Endo Health Solutions Inc, #13 Exhibit 12 to Complaint: Demand Letter to Endo Pharmaceuticals Inc, #14 Exhibit 13 to Complaint: Demand Letter to Insys Therapeutics Inc, #15 Exhibit 14 to Complaint: Demand Letter to Janssen Pharmaceutica Inc, #16 Exhibit 15 to Complaint : Demand Letter to Janssen Pharmaceutica Inc, #17 Exhibit 16 to Complaint: Demand Letter to Johnson & Johnson, #18 Exhibit 17 to Complaint: Demand Letter to Dr. Jorgensen, #19 Exhibit 18 to Complaint: Demand Letter to Mallinckrodt Enterprises LLC, #20 Exhibit 19 to Complaint: Demand Letter to McKesson Corp, #21 Exhibit 20 to Complaint: Demand Letter to Ortho McNeil-Janssen Pharmaceuticals, #22 Exhibit 21 to Complaint: Demand Letter to The Purdue Frederick Co, #23 Exhibit 22 to Complaint: Demand Letter to Purdue Pharma LP, #24 Exhibit 23 to Complaint: Demand Letter to Purdue Pharma Inc, #25 Exhibit 24 to Complaint: Demand Letter to Teva Pharmaceuticals USA Inc, #26 Exhibit 25 to Complaint : Demand Letter to Watson Laboratories Inc, #27 McKesson Corp's Assented to Motion to Extend Deadline, #28 Notice of Entry of Appearance Hanlon, #29 AmerisourceBergen Drug Corp's Consent Motion for Extension of Time)(mnw) |
| Filing 33 CORPORATE DISCLOSURE STATEMENT by WALGREENS BOOTS ALLIANCE INC. (CAHOON, JOSEPH) |
| Filing 32 NOTICE of Appearance by JAMES M. CAMPBELL on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (CAMPBELL, JAMES) |
| Filing 31 STATE COURT RECORD with Affidavit by AMERISOURCEBERGEN DRUG CORPORATION. (DUNLAP, JOSHUA) |
| Filing 30 CORPORATE DISCLOSURE STATEMENT by JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC. (SCHAFFER, MICHELLE) |
| Filing 29 CERTIFICATION for Admission Pro Hac Vice of Charles C. Lifland filed by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (Total admission fee $ 100 receipt number 0100-1986909.) (SCHAFFER, MICHELLE) |
| Filing 28 NOTICE of Appearance by MICHELLE I. SCHAFFER on behalf of JANSSEN PHARMACEUTICA INC, JANSSEN PHARMACEUTICALS INC, JOHNSON & JOHNSON, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC (SCHAFFER, MICHELLE) |
| Filing 27 CORPORATE DISCLOSURE STATEMENT by ALLERGAN FINANCE LLC. (SCHUTZ, SIGMUND) |
| Filing 26 CERTIFICATION for Admission Pro Hac Vice of Donna M. Welch filed by SIGMUND D. SCHUTZ on behalf of ALLERGAN FINANCE LLC (Total admission fee $ 100 receipt number 0100-1986775.) (SCHUTZ, SIGMUND) |
|
Filing 25
ORDER granting without objection #21 Motion to Extend Time to File Response to Complaint. Time is extended for all Defendants to (1) 30 days after this Court rules on any motion to remand that might be filed, or (2) 30 days after the Judicial Panel on Multidistrict Litigation issues a final decision as to whether to transfer the case to the Multidistrict Litigation, whichever date is later. By MAGISTRATE JUDGE JOHN C. NIVISON. (NIVISON, JOHN)
|
| Filing 24 CERTIFICATION for Admission Pro Hac Vice of Mark S. Cheffo filed by RITCHIE E. BERGER on behalf of PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP (Total admission fee $ 100 receipt number 0100-1986088.) (BERGER, RITCHIE) |
| Filing 23 CORPORATE DISCLOSURE STATEMENT by PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP. (BERGER, RITCHIE) |
| Filing 22 NOTICE of Appearance by RITCHIE E. BERGER on behalf of PURDUE FREDERICK COMPANY, PURDUE PHARMA INC, PURDUE PHARMA LP (BERGER, RITCHIE) |
| Filing 21 Consent MOTION to Extend Time to File Answer by AMERISOURCEBERGEN DRUG CORPORATION, CARDINAL HEALTH 110 LLC, MCKESSON CORPORATION Responses due by 3/28/2019. (DUNLAP, JOSHUA) |
| Filing 20 CORPORATE DISCLOSURE STATEMENT by RITE AID CORPORATION, RITE AID OF MAINE INC, RITE AID OF MARYLAND INC. (PETRUCCELLI, GERALD) |
| Filing 19 NOTICE of Appearance by GERALD F. PETRUCCELLI on behalf of RITE AID CORPORATION, RITE AID OF MAINE INC, RITE AID OF MARYLAND INC (PETRUCCELLI, GERALD) |
| Filing 18 CORPORATE DISCLOSURE STATEMENT by INSYS THERAPEUTICS INC. (MALONE, KELLY) |
| Filing 17 CORPORATE DISCLOSURE STATEMENT by WALMART INC. (MAWHINNEY, DANIEL) |
| Filing 16 CERTIFICATION for Admission Pro Hac Vice of Christopher Lovrien filed by DANIEL R. MAWHINNEY on behalf of WALMART INC (Total admission fee $ 100 receipt number 0100-1985568.) (MAWHINNEY, DANIEL) |
| Filing 15 NOTICE of Appearance by TIMOTHY C. WOODCOCK on behalf of MALLINCKRODT ENTERPRISES LLC (WOODCOCK, TIMOTHY) |
| Filing 14 CERTIFICATION for Admission Pro Hac Vice of Andrew J. O'Connor and Brien T. O'Connor filed by TIMOTHY C. WOODCOCK on behalf of MALLINCKRODT ENTERPRISES LLC (Total admission fee $ 200 receipt number 0100-1985248.) (Attachments: #1 Certification for Admission Pro Hac Vice - Brien T. O'Connor)(WOODCOCK, TIMOTHY) |
| Filing 13 CORPORATE DISCLOSURE STATEMENT by MALLINCKRODT ENTERPRISES LLC. (WOODCOCK, TIMOTHY) |
| Filing 12 CORPORATE DISCLOSURE STATEMENT by ACTAVIS LLC, ACTAVIS PHARMA INC, CEPHALON INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC. (GOLDMAN, JEFF) |
| Filing 11 CERTIFICATION for Admission Pro Hac Vice of Ryan Zane Watts filed by KAREN FRINK WOLF on behalf of ENDO HEALTH SOLUTIONS INC, ENDO PHARMACEUTICALS INC (Total admission fee $ 100 receipt number 0100-1985175.) (WOLF, KAREN) |
| Filing 10 CORPORATE DISCLOSURE STATEMENT by ENDO HEALTH SOLUTIONS INC, ENDO PHARMACEUTICALS INC. (WOLF, KAREN) |
| Filing 9 ACKNOWLEDGEMENT OF SERVICE Executed as to Defendants. (Attachments: #1 Acceptance of Service-Actavis LLC, Actavis Pharma, Cephalon, Teva Pharmaceuticals USA, Watson Lab, #2 Acceptance of Service-Allergan Finance, #3 Acceptance of Service-AmerisourceBergen, #4 Acceptance of Service-Drs. Bruehl and Cieniawski, #5 Acceptance of Service-Cardinal, #6 Acceptance of Service-CVS, #7 Acceptance of Service-Endo Health and Endo Pharm, #8 Acceptance of Service-Insys, #9 Acceptance of Service-Janssen Pharmaceutica, Janssen Pharmaceuticals, Ortho-McNeil-Janssen, #10 Acceptance of Service-Dr. Jorgensen, #11 Acceptance of Service-Mallinckrodt, #12 Acceptance of Service-McKesson, #13 Acceptance of Service-Purdue Pharma Inc., Purdue Pharma LP, Purdue Frederick, #14 Acceptance of Service-Rite Aid Corp, Rite Aid of ME, Rite Aid of MD, #15 Acceptance of Service-Walgreens, #16 Acceptance of Service-Walmart)(BELLEAU, JAMES) |
| Filing 8 CERTIFICATION for Admission Pro Hac Vice of Conor B. O'Croinin filed by GERALDINE G. SANCHEZ on behalf of CVS PHARMACY INC (Total admission fee $ 100 receipt number 0100-1984823.) (SANCHEZ, GERALDINE) |
| Filing 7 CORPORATE DISCLOSURE STATEMENT by CVS PHARMACY INC. (SANCHEZ, GERALDINE) |
| Filing 6 LETTER from the Clerk's Office to the Clerk of the MDL panel. (mnw) |
| Filing 5 PROCEDURAL ORDER RE: REMOVAL: State Court Record due by 3/12/2019. By Melody Whitten, Deputy Clerk (mnw) |
| Filing 4 CORPORATE DISCLOSURE STATEMENT by MCKESSON CORPORATION. (HANLON, MELISSA) |
| Filing 3 CORPORATE DISCLOSURE STATEMENT by AMERISOURCEBERGEN DRUG CORPORATION. (sfw) |
| Filing 2 CIVIL COVER SHEET. (sfw) |
| Filing 1 NOTICE OF REMOVAL with State Court Pleadings Complaint from York County Superior Court, case number CV-19-08. PAYMENT OF FILING FEE DUE WITHIN 48 HOURS. IF FILING FEE IS BEING PAID WITH A CREDIT CARD COUNSEL ARE INSTRUCTED TO LOGIN TO CMECF AND DOCKET Case Opening Filing Fee Paid FOUND IN THE Complaints and Other Initiating Documents CATEGORY. CHECK PAYMENTS DUE WITHIN 48 HOURS., filed by AMERISOURCEBERGEN DRUG CORPORATION. (Service of Process Deadline 5/30/2019) Fee due by 3/4/2019. (Attachments: #1 Declaration of Joshua Dunlap, #2 State Court Complaint, #3 Exhibit 1 to Complaint: Demand letter to Actavis Inc f/k/a Watson Pharmaceuticals Inc, #4 Exhibit 2 to Complaint: Demand letter to Actavis LLC, #5 Exhibit 3 to Complaint: Demand letter to Actavis Pharma Inc f/k/a Watson Pharma Inc, #6 Exhibit 4 to Complaint: Demand letter to Allergan PLC f/k/a Actavis Plc, #7 Exhibit 5 to Complaint: Demand letter to Allergan PLC f/k/a Actavis Plc, #8 Exhibit 6 to Complaint: Demand letter to Amerisourcebergen Corporation, #9 Exhibit 7 to Complaint: Demand letter toto Dr. Bruehl MD, #10 Exhibit 8 to Complaint: Demand letter to Cardinal Health Inc, #11 Exhibit 9 to Complaint: Demand letter to Cephalon Inc, #12 Exhibit 10 to Complaint: Demand letter to Dr. Cieniawski MD, #13 Exhibit 11 to Complaint: Demand letter to Endo Health Solutions Inc, #14 Exhibit 12 to Complaint: Demand letter to Endo Pharmaceuticals Inc, #15 Exhibit 13 to Complaint: Demand letter to Insys Therapeutics Inc, #16 Exhibit 14 to Complaint: Demand letter to Janssen Pharmaceutica Inc n/k/a Janssen Pharmaceuticals Inc, #17 Exhibit 15 to Complaint: Demand letter to Janssen Pharmaceutica Inc n/k/a Janssen Pharmaceuticals Inc, #18 Exhibit 16 to Complaint: Demand letter to Johnson & Johnson, #19 Exhibit 17 to Complaint: Demand letter to Douglas J. Jorgensen DO, #20 Exhibit 18 to Complaint: Demand letter to Mallinckrodt Enterprises LLC, #21 Exhibit 19 to Complaint: Demand letter to Mckesson Corporation, #22 Exhibit 20 to Complaint: Demand letter to Orthomcneil-Janssen Pharmaceuticals Inc n/k/a Janssen Pharmaceuticals Inc, #23 Exhibit 21 to Complaint: Demand letter to Purdue Frederick Company Inc, #24 Exhibit 22 to Complaint: Demand letter to Purdue Pharma LP, #25 Exhibit 23 to Complaint: Demand letter to Purdue Pharma Inc, #26 Exhibit 24 to Complaint: Demand letter to Teva Pharmaceuticals USA Inc, #27 Exhibit 25 to Complaint: Demand letter to Watson Laboratories Inc)(sfw) |
| Filing Fee Paid via Credit Card ( Filing fee $ 400 receipt number 0100-1983043.), filed by AMERISOURCEBERGEN DRUG CORPORATION.(DUNLAP, JOSHUA) |
| Set Deadlines : Per Local Rule 7.1 Notice of Interested Parties or Corporate Disclosure Statement from PURDUE PHARMA LP, PURDUE PHARMA INC, PURDUE FREDERICK COMPANY, TEVA PHARMACEUTICALS USA INC, CEPHALON INC, JOHNSON & JOHNSON, JANSSEN PHARMACEUTICALS INC. ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS INC, JANSSEN PHARMACEUTICA INC, ENDO PHARMACEUTICALS INC, ALLERGAN FINANCE LLC, WATSON LABORATORIES INC, ACTAVIS LLC, ACTAVIS PHARMA INC, ENDO HEALTH SOLUTIONS INC, INSYS THERAPEUTICS INC, MALLINCKRODT ENTERPRISES LLC, MCKESSON CORPORATION, CARDINAL HEALTH 110 LLC, CVS PHARMACY INC, WALGREENS BOOTS ALLIANCE INC WALMART INC, RITE AID CORPORATION, RITE AID OF MARYLAND INC, RITE AID OF MAINE INC due by 3/8/2019. (sfw) |
| Set Deadlines : Pro Hac Vice Certificate due from MARK CHEFFO, CHARLES C. LIFLAND, DONNA WELCH, CONOR B. O'CROININ by 3/8/2019. The Certification for Admission Pro Hac Vice form can be downloaded from our website at #http://www.med.uscourts.gov/forms. (sfw) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Maine District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
